Comparison and analyses of therapeutic effects between metabolic management center (MMC) and conventional management modes
- 1 September 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Diabetologica
- Vol. 57 (9), 1049-1056
- https://doi.org/10.1007/s00592-020-01518-4
Abstract
Aims The past 3 decades witnessed the rapid growth of diabetes in China. To better serve large numbers of patients, the Chinese Medical Doctor Association launched metabolic management center (MMC) program which is featured with a one-stop and comprehensive diabetes management mode in 2016. It is worth exploring whether MMC model is better than conventional models in management. Methods In this study, 228 patients with type 2 diabetes were recruited, and 193 patients completed the study. Therapeutic effects and health care costs were analyzed. Results and Conclusions Our results showed that decreases in HbA(1C) and TG/HDL-C values were significantly greater in the MMC group than in the control group. The increase in HDL-C was significantly higher in the MMC group than in the control group. The percentage of patients whose HbA(1C) lower than 7% was significantly higher in the MMC group. The results of the UKPDS model simulation showed that within 30 years, with the slight increases in treatment costs, the average life expectancy and total QALE of the MMC group are higher than those of the control group by 0.61 and 0.51 year, respectively. Further study showed that the drug intervention in the MMC group was significantly stronger. In addition, the questionnaires revealed that MMC group performed better in diabetes knowledge tests and have higher patient satisfaction rates of medical services. More patients in the MMC group adopted a more favorable diet strategy. These advantages enable MMC to achieve more short-term and long-term benefits in diabetes treatment than conventional mode.Keywords
Funding Information
- Natural Science Foundation of Tongzhou District (KJ2019CX013)
This publication has 21 references indexed in Scilit:
- Diabetes: a metabolic and reproductive disorder in womenThe Lancet Diabetes & Endocrinology, 2019
- Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort studyJournal of Diabetes Investigation, 2019
- Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese AdultsDiabetes Care, 2019
- Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in ChinaJournal of Diabetes, 2018
- Clinical management of type 2 diabetes in south AsiaThe Lancet Diabetes & Endocrinology, 2018
- Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized MedicationDiabetes, 2017
- 12. Children and Adolescents: Standards of Medical Care in Diabetes—2018Diabetes Care, 2017
- Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetesThe Lancet Diabetes & Endocrinology, 2017
- How to prevent the microvascular complications of type 2 diabetes beyond glucose controlBMJ, 2017
- Type 2 diabetes mellitusNature Reviews Disease Primers, 2015